These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8205315)

  • 21. Cardiac hypertrophy in deceased users of anabolic androgenic steroids: an investigation of autopsy findings.
    Far HR; Ågren G; Thiblin I
    Cardiovasc Pathol; 2012; 21(4):312-6. PubMed ID: 22104006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of testosterone and anabolic steroids on the size of sebaceous glands in power athletes.
    Király CL; Collan Y; Alén M
    Am J Dermatopathol; 1987 Dec; 9(6):515-9. PubMed ID: 3445928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistent primary hypogonadism associated with anabolic steroid abuse.
    Boregowda K; Joels L; Stephens JW; Price DE
    Fertil Steril; 2011 Jul; 96(1):e7-8. PubMed ID: 21575947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anabolic steroids: damages, effect on performance, and on metabolism (author's transl)].
    Keul J; Deus B; Kindermann W
    Med Klin; 1976 Mar; 71(12):497-503. PubMed ID: 1263996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dilated cardiomyopathy and acute liver injury associated with combined use of ephedra, gamma-hydroxybutyrate, and anabolic steroids.
    Clark BM; Schofield RS
    Pharmacotherapy; 2005 May; 25(5):756-61. PubMed ID: 15899737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An acute myocardial infarction occurring in an anabolic steroid user.
    Huie MJ
    Med Sci Sports Exerc; 1994 Apr; 26(4):408-13. PubMed ID: 8201894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids.
    Lane HA; Grace F; Smith JC; Morris K; Cockcroft J; Scanlon MF; Davies JS
    Eur J Clin Invest; 2006 Jul; 36(7):483-8. PubMed ID: 16796605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heart lesions associated with anabolic steroid abuse: comparison of post-mortem findings in athletes and norethandrolone-induced lesions in rabbits.
    Fanton L; Belhani D; Vaillant F; Tabib A; Gomez L; Descotes J; Dehina L; Bui-Xuan B; Malicier D; Timour Q
    Exp Toxicol Pathol; 2009 Jul; 61(4):317-23. PubMed ID: 19027274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acne induced by 'Sus' and 'Deca'.
    Walker SL; Parry EJ
    Clin Exp Dermatol; 2006 Mar; 31(2):297-8. PubMed ID: 16487124
    [No Abstract]   [Full Text] [Related]  

  • 30. Extreme hyperbilirubinemia associated with the use of anabolic steroids, health/nutritional supplements, and ethanol: response to ursodeoxycholic acid treatment.
    Singh C; Bishop P; Willson R
    Am J Gastroenterol; 1996 Apr; 91(4):783-5. PubMed ID: 8677950
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature.
    Socas L; Zumbado M; Pérez-Luzardo O; Ramos A; Pérez C; Hernández JR; Boada LD
    Br J Sports Med; 2005 May; 39(5):e27. PubMed ID: 15849280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Image of the month. Gymnasium acne: a fulminant doping acne].
    Piérard GE
    Rev Med Liege; 1998 Aug; 53(8):441-3. PubMed ID: 9810201
    [No Abstract]   [Full Text] [Related]  

  • 33. Increased left ventricular mass in a bodybuilder using anabolic steroids.
    McKillop G; Todd IC; Ballantyne D
    Br J Sports Med; 1986 Dec; 20(4):151-2. PubMed ID: 2949795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sudden cardiac death during exercise in a weight lifter using anabolic androgenic steroids: pathological and toxicological findings.
    Luke JL; Farb A; Virmani R; Sample RH
    J Forensic Sci; 1990 Nov; 35(6):1441-7. PubMed ID: 2148179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poststeroid balance disorder--a case report in a body builder.
    Bochnia M; Medraś M; Pośpiech L; Jaworska M
    Int J Sports Med; 1999 Aug; 20(6):407-9. PubMed ID: 10496122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proposed mechanisms for the anabolic steroid-induced increase in myocardial susceptibility to ischaemia/reperfusion injury.
    Du Toit EF; Rossouw E; Van Rooyen J; Lochner A
    Cardiovasc J S Afr; 2005; 16(1):21-8. PubMed ID: 15778771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Appearance/Image- and Performance-Enhancing Drug Users: A Forensic Approach.
    Lusetti M; Licata M; Silingardi E; Bonsignore A; Palmiere C
    Am J Forensic Med Pathol; 2018 Dec; 39(4):325-329. PubMed ID: 30153114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Building your body to survive: the use of anabolic steroids for HIV therapy.
    Vergel N
    Posit Aware; 1998; 9(2):37-41. PubMed ID: 11365225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversible hypogonadism and azoospermia as a result of anabolic-androgenic steroid use in a bodybuilder with personality disorder. A case report.
    Boyadjiev NP; Georgieva KN; Massaldjieva RI; Gueorguiev SI
    J Sports Med Phys Fitness; 2000 Sep; 40(3):271-4. PubMed ID: 11125771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The dark side of beauty: acne fulminans induced by anabolic steroids in a male bodybuilder.
    Kraus SL; Emmert S; Schön MP; Haenssle HA
    Arch Dermatol; 2012 Oct; 148(10):1210-2. PubMed ID: 23069972
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.